About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Treatment for Speech and Language in Primary Progressive Aphasia

Treatment for Speech and Language in Primary Progressive Aphasia

NCT04881617·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Texas at Austin

With

National Institute on Deafness and Other Communication Disorders (NIDCD)
University of California, San Francisco

Age

Any age

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
Score of 15 or higher on the Mini-Mental State Examination

You may not be if

Other neurological or psychiatric diagnosis that may contribute to cognitive-linguistic deficits
Significant, uncorrected visual or hearing impairment that would interfere with participation
Score of less than 15 on the Mini-Mental State Examination
Prominent initial non-speech-language impairment (cognitive, behavioral, motoric)

The record

StatusActive not recruiting

PhaseNo phase

Taking part60

StartedJul 2017

UpdatedNov 13, 2025

Conditions

Primary Progressive Aphasia Semantic Dementia Semantic Memory Disorder Logopenic Progressive Aphasia Nonfluent Aphasia, Progressive+2

Where2

University of California San Francisco
San Francisco, California, United States
University of Texas
Austin, Texas, United States